Table 2 Clinical presentation of COVID-19 in children with rheumatic diseases
From: Outcomes of COVID-19 in a cohort of pediatric patients with rheumatic diseases
| Symptoms |
Total n = 55 |
Hospitalized n = 10 | Ambulatory n = 45 |
OR (95% CI) | P | |||
|---|---|---|---|---|---|---|---|---|
| Fever | 17 | (30.9) | 7 | (70.0) | 10 | (22.2) | 7.78 (1.46–55.38) | 0.006 |
| Rhinorrhea/Congestion | 13 | (23.6) | 2 | (20.0) | 11 | (24.4) | 0.78 (0.07–4.79) | 1 |
| Cough | 20 | (36.4) | 4 | (40.0) | 16 | (35.6) | 1.20 (0.22–5.99) | 1 |
| Dyspnea | 5 | (9.1) | 4 | (40.0) | 1 | (2.2) | 26.28 (2.17–1459.25) | 0.003 |
| Chest pain | 6 | (6) | 4 | (40.0) | 2 | (4.4) | 13.20 (1.53–175.79) | 0.007 |
| Myalgias | 12 | (21.8) | 5 | (50.0) | 7 | (15.6) | 5.21 (0.94–30.12) | 0.03 |
| Abdominal pain | 4 | (7.3) | 2 | (20.0) | 2 | (4.4) | 5.14 (0.32–80.65) | 0.15 |
| Anorexia/Nausea/Emesis | 8 | (14.5) | 3 | (30.0) | 5 | (11.1) | 3.33 (0.42–22.34) | 0.15 |
| Diarrhea | 10 | (18.2) | 4 | (40.0) | 6 | (13.3) | 4.18 (0.67–24.99) | 0.07 |
| Anosmia/Ageusia | 14 | (25.5) | 2 | (20.0) | 12 | (26.7) | 0.69 (0.06–4.21) | 1 |
| Rash | 5 | (9.1) | 4 | (40.0) | 1 | (2.2) | 26.28 (2.17–1459.25) | 0.003 |
| Fatigue/Malaise | 16 | (29.1) | 2 | (20.0) | 14 | (31.1) | 0.56 (0.05–3.34) | 0.7 |
| Sore throat | 12 | (21.8) | 2 | (20.0) | 10 | (22.2) | 0.88 (0.08–5.50) | 1 |
| Headache | 12 | (21.8) | 2 | (20.0) | 10 | (22.2) | 0.88 (0.08–5.50) | 1 |
| Asymptomatic | 10 | (18.2) | 0 | (0.0) | 10 | (22.2) | 0 (0–1.92) | 0.18 |